Ensign Peak Advisors, Inc Invitae Corp Transaction History

Ensign Peak Advisors, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.13 - $9.01 $93,975 - $397,521	-44,120 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$14.7 - $28.67 $425,462 - $829,795	-28,943 Reduced 39.61%	44,120 $674,000
Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $535,792 - $740,544	22,040 Added 43.2%	73,063 $2.08 Million
Q1 2021 May 12, 2021	SELL	$33.06 - $56.93 $336,914 - $580,173	-10,191 Reduced 16.65%	51,023 $1.95 Million
Q3 2020 Nov 12, 2020	BUY	$28.43 - $44.67 $1.74 Million - $2.73 Million	61,214 New	61,214 $2.65 Million
Q1 2020 May 11, 2020	SELL	$7.64 - $27.5 $60,822 - $218,927	-7,961 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$15.02 - $20.57 $119,574 - $163,757	7,961 New	7,961 $128,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.